Dr. Sami H. Uwaydat, MD

Dr. Uwaydat practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Uwaydat's NPI, 1679798698, was assigned on April 16, 2007. Dr. Uwaydat holds Arkansas license E-5758.

Dr. Uwaydat's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Uwaydat's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Dr. Uwaydat is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Uwaydat to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uwaydat practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Uwaydat's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Uwaydat is licensed in Arkansas.

CMS data shows 2,748 Medicare services from Dr. Uwaydat across 14 procedure codes in 2024, for 585 Medicare patients. Medicare paid $117,939 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 585 Medicare patients who saw Dr. Uwaydat in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uwaydat's median patient age at 67, with 59% women.

In 2024, Dr. Uwaydat wrote 284 Medicare Part D claims for 73 patients. 69% of them were for generic drugs. CMS names the drug for 236 of them, across 7 drugs with 11 or more claims each, at $4,294 in total drug cost. In 2023, CMS named 141 claims across 7 drugs.

Dr. Uwaydat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of cataract surgery by Dr. Uwaydat, more than 66% of the clinicians it reports for that procedure.

CMS Open Payments shows 3 general payments to Dr. Uwaydat from 3 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 67% of the total. Genentech, Inc. paid the most, $2,430.